192 related articles for article (PubMed ID: 30652764)
41. Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting.
Barkana Y; Almer Z; Segal O; Lazarovitch Z; Avni I; Zadok D
Acta Ophthalmol Scand; 2005 Jun; 83(3):360-3. PubMed ID: 15948791
[TBL] [Abstract][Full Text] [Related]
42. Reduction of endophthalmitis rate after cataract surgery with preoperative 5% povidone-iodine.
Trinavarat A; Atchaneeyasakul LO; Nopmaneejumruslers C; Inson K
Dermatology; 2006; 212 Suppl 1():35-40. PubMed ID: 16490973
[TBL] [Abstract][Full Text] [Related]
43. Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.
Dave SB; Toma HS; Kim SJ
Ophthalmology; 2011 Oct; 118(10):2035-40. PubMed ID: 21856006
[TBL] [Abstract][Full Text] [Related]
44. Controversies in Topical Antibiotics Use with Intravitreal Injections.
Schwartz SG; Flynn HW; Grzybowski A
Curr Pharm Des; 2015; 21(32):4703-6. PubMed ID: 26350527
[TBL] [Abstract][Full Text] [Related]
45. A prospective study demonstrating the effect of 5% povidone-iodine application for anterior segment intraocular surgery in Paraguay.
Quiroga LP; Lansingh V; Laspina F; Samudio M; Stanley J; Kaspar HM; Cibils D; Cibils P
Arq Bras Oftalmol; 2010; 73(2):125-8. PubMed ID: 20549039
[TBL] [Abstract][Full Text] [Related]
46. Aqueous chlorhexidine (0.1%) is an effective alternative to povidone-iodine for intravitreal injection prophylaxis.
Oakley CL; Vote BJ
Acta Ophthalmol; 2016 Dec; 94(8):e808-e809. PubMed ID: 26947261
[No Abstract] [Full Text] [Related]
47. [Efficacy of topical 0.3% ciprofloxacin application in reducing the conjunctival biota of patients undergoing cataract extraction].
Carron A; Samudio M; Laspina F; Fariña N; Sanabria RR; Cibils D; Ramirez L; Carron J; Mino de Kaspar H
Arch Soc Esp Oftalmol; 2013 Sep; 88(9):345-51. PubMed ID: 23988041
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections.
Kim SJ; Toma HS
Arch Ophthalmol; 2011 Sep; 129(9):1180-8. PubMed ID: 21911665
[TBL] [Abstract][Full Text] [Related]
49. Elimination of Topical Antibiotics for Intravitreous Injections and the Importance of Using Povidone-Iodine: Update From the Diabetic Retinopathy Clinical Research Network.
Bhavsar AR; Glassman AR; Stockdale CR; Jampol LM;
JAMA Ophthalmol; 2016 Oct; 134(10):1181-1183. PubMed ID: 27533136
[TBL] [Abstract][Full Text] [Related]
50. Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis.
Kowalski RP; Romanowski EG; Shanks RMQ; Mammen A; Dhaliwal DK
Eye Contact Lens; 2018 Nov; 44 Suppl 2():S338-S343. PubMed ID: 29944493
[TBL] [Abstract][Full Text] [Related]
51. Prospective study demonstrating the efficacy of combined preoperative three-day application of antibiotics and povidone-iodine irrigation.
Ta CN; Lin RC; Singh G; Miño de Kaspar H
Ann Ophthalmol (Skokie); 2007; 39(4):313-7. PubMed ID: 18025652
[TBL] [Abstract][Full Text] [Related]
52. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
[TBL] [Abstract][Full Text] [Related]
53. Comparison of 1-day versus 1-hour application of topical neomycin/polymyxin-B before cataract surgery.
Li B; Miño de Kaspar H; Haritoglou C; Kook D; Kampik A; Sheng M; Nentwich MM
J Cataract Refract Surg; 2015 Apr; 41(4):724-31. PubMed ID: 25840297
[TBL] [Abstract][Full Text] [Related]
54. Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center.
Nentwich MM; Yactayo-Miranda Y; Schwarzbach F; Wolf A; Kampik A; Mino de Kaspar H
Retina; 2014 May; 34(5):943-50. PubMed ID: 24136408
[TBL] [Abstract][Full Text] [Related]
55. Aqueous chlorhexidine is an effective alternative to povidone-iodine for intravitreal injection prophylaxis.
Oakley CL; Vote BJ
Acta Ophthalmol; 2017 Dec; 95(8):e794. PubMed ID: 28261932
[No Abstract] [Full Text] [Related]
56. DILUTE POVIDONE-IODINE PROPHYLAXIS MAINTAINS SAFETY WHILE IMPROVING PATIENT COMFORT AFTER INTRAVITREAL INJECTIONS.
Peden MC; Hammer ME; Suñer IJ
Retina; 2019 Nov; 39(11):2219-2224. PubMed ID: 30142109
[TBL] [Abstract][Full Text] [Related]
57. In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation.
Musumeci R; Bandello F; Martinelli M; Calaresu E; Cocuzza CE
Eur J Ophthalmol; 2019 Nov; 29(6):673-677. PubMed ID: 30295039
[TBL] [Abstract][Full Text] [Related]
58. The comparison of fluoroquinolones to nonfluoroquinolone antibacterial agents for the prevention of endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Shanks RM; Mah FS
J Ocul Pharmacol Ther; 2012 Dec; 28(6):604-8. PubMed ID: 22925112
[TBL] [Abstract][Full Text] [Related]
59. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
60. Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment.
Alexandrou TJ; Hariprasad SM; Benevento J; Rubin MP; Saidel M; Ksiazek S; Thompson K; Boonlayangoor S; Mieler WF
Trans Am Ophthalmol Soc; 2006; 104():196-201. PubMed ID: 17471340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
